Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Item

http://www.wikidata.org/entity/Q34232517

Q34232517

about

Inducing and Administering Tregs to Treat Human Disease Induction of immunological tolerance by oral anti-CD3 IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation Clinical tolerance in allogeneic hematopoietic stem cell transplantation.Emulsomes meet S-layer proteins: an emerging targeted drug delivery system.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis.Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs.Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.Your nose knows how to target brain inflammation Therapeutic targeting of B cells and T cells in autoimmune diabetes: is it a solution?Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases Oral Solution Ameliorates Allergic Asthma in Children by Regulating Relative Contents of CD4CD25CD127 Treg Cells Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis

P2860

Q26772723-EC683103-1190-438F-A044-B905EA2F2901 Q26863556-2A25BEC6-C780-47E3-AB6A-44E0B9592F7A Q37081950-3C2D7988-F3D3-4D27-A5A8-39208B29B1F5 Q37864697-545CBA47-C5B9-4D87-880C-B53F7AB22C17 Q38361935-3A32823A-4C23-45F3-8654-370B714DEE9B Q38620803-4415694F-5162-40DF-A094-854E4FB46504 Q38830417-25B15ECB-3CC5-4D35-AF3B-EDE9700E774C Q39017833-CF5D73C8-FB41-4DAC-9B68-827A7CA79C79 Q39210713-42761026-3BA3-44A1-958D-92A301B7615F Q39785440-1547550F-0FF6-4531-B683-FA9F917B1645 Q41057184-5F3C3A85-1F7E-4AB9-9B18-7EBEB6A2C86E Q41654330-0C3CE4F3-19AF-43FC-A0B9-EF1803EFFA14 Q42426565-CF8197BC-CBAA-40DA-8AE9-F79C3F538768 Q42869996-EE05E970-5075-4872-8357-A285E7E2A437 Q53556158-C863726A-11C0-4E87-A38C-1A8399FA02F1 Q56891645-05A1E297-3028-4968-8CAD-E5F58239AE7A Q57191802-59D21410-DB96-498D-9A67-6AA0B309F151 Q57210121-06B598C7-D339-4F37-AD64-FACA3B04CE56 Q58693554-60950A41-FE60-4730-B5FC-2AC4E1E6A3D6

P2860

Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Item

http://www.wikidata.org/entity/Q34232517

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu